NNCSF Stock Chart & Stats
$2.03
<$0.01(0.23%)
At close: 4:00 PM EDT
$2.03
<$0.01(0.23%)
Day’s Range― - ―
52-Week Range$1.74 - $3.05
Previous CloseN/A
Volume500.00
Average Volume (3M)185.00
Market Cap
$637.16M
Enterprise Value$896.46M
Total Cash (Recent Filing)$155.22M
Total Debt (Recent Filing)$23.13M
Price to Earnings (P/E)51.4
Beta0.42
Next Earnings
Feb 23, 2027EPS Estimate
0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.06
Shares Outstanding299,167,630
10 Day Avg. Volume0
30 Day Avg. Volume185
Financial Highlights & Ratios
PEG Ratio-4.18
Price to Book (P/B)4.63
Price to Sales (P/S)4.95
P/FCF Ratio57.84
Enterprise Value/Market Cap1.41
Enterprise Value/Revenue4.41
Enterprise Value/Gross Profit5.73
Enterprise Value/Ebitda37.82
Forecast
1Y Price Target
$2.62Price Target Upside28.88% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering3
EPS Forecast (FY)0.02
Revenue Forecast (FY)$154.04M
Bulls Say, Bears Say
Bulls Say
Recurring Installed-base RevenueThe expanding trophon installed base supports recurring consumables and service demand, creating a durable revenue stream beyond equipment placements. Continued annuity growth also improves visibility and allows higher utilisation of the company’s commercial infrastructure over the next several quarters.
Strong Trophon ProfitabilityTrophon’s profitability and cash generation provide a durable financial engine for funding product development, commercial expansion and shareholder returns. This established franchise can support the business while newer platforms scale, reducing reliance on immediate success from a single launch.
CORIS Regulatory And Growth PlatformRegulatory progress across multiple markets materially expands CORIS’s commercial pathway and supports a broader healthcare technology portfolio. Its higher capital pricing, cycle economics and service potential could add a substantial growth platform as adoption develops beyond the initial launch period.
Bears Say
FY2026 Growth And Margin SoftnessThe FY2026 revenue decline and lower net margin indicate that recent expansion has not translated into consistently improving earnings efficiency. If this pattern persists, weaker operating leverage could constrain internal funding capacity and make future growth more dependent on successful product execution.
Weaker Cash ConversionPositive cash generation remains intact, but the sharp FY2026 decline and operating cash flow below accounting earnings signal less reliable cash conversion. Persistent working-capital or timing pressure could reduce flexibility for investment, buybacks and absorbing launch-related spending.
CORIS Launch Investment PressureCORIS requires substantial near-term operating investment while contributing only modest launch-year revenue, creating a temporary drag on earnings leverage. The business must sustain this spending until adoption accelerates, leaving execution and commercialization outcomes important to medium-term returns.
Nanosonics Limited News
NNCSF FAQ
What was Nanosonics Limited’s price range in the past 12 months?
Nanosonics Limited lowest stock price was $1.74 and its highest was $3.05 in the past 12 months.
What is Nanosonics Limited’s market cap?
Nanosonics Limited’s market cap is $637.16M.
When is Nanosonics Limited’s upcoming earnings report date?
Nanosonics Limited’s upcoming earnings report date is Feb 23, 2027 which is in 115 days.
How were Nanosonics Limited’s earnings last quarter?
Nanosonics Limited released its earnings results on Aug 24, 2026. The company reported $0.021 earnings per share for the quarter, beating the consensus estimate of $0.018 by $0.003.
Is Nanosonics Limited overvalued?
According to Wall Street analysts Nanosonics Limited’s price is currently Undervalued.
Does Nanosonics Limited pay dividends?
Nanosonics Limited does not currently pay dividends.
What is Nanosonics Limited’s EPS estimate?
Nanosonics Limited’s EPS estimate is 0.01.
How many shares outstanding does Nanosonics Limited have?
Nanosonics Limited has 299,167,630 shares outstanding.
What happened to Nanosonics Limited’s price movement after its last earnings report?
Nanosonics Limited reported an EPS of $0.021 in its last earnings report, beating expectations of $0.018. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Nanosonics Limited?
Currently, no hedge funds are holding shares in NNCSF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Nanosonics Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.62 (28.88% Upside)
$2.62 (28.88% Upside)
Blogger Sentiment
Bullish
NNCSF Sentiment 100%
Sector Average 64%
Sector Average 64%
Insider Transactions
Bought Shares
Worth $94.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.66%
12-Months-Change
Fundamentals
Return on Equity
8.16%
Trailing 12-Months
Asset Growth
18.98%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Nanosonics Limited
Nanosonics Limited, along with its subsidiaries, functions as a global infection prevention enterprise with operations in Australia and beyond. The company focuses on the production and distribution of its trophon ultrasound probe disinfection system, including all related supplies and accessories. Additionally, it dedicates resources to the exploration, development, and market launch of innovative infection control, decontamination products, and their associated technologies. Key offerings from Nanosonics include trophon2, an advanced device for high-level disinfection of ultrasound probes; trophon EPR, a low-temperature, high-level disinfection method specifically for intra-cavity ultrasound probes; and Nanosonics AuditPro, a comprehensive solution for managing compliance with infection control workflows. Established in 2000, Nanosonics Limited is headquartered in Macquarie Park, Australia.
NNCSF Company Deck
NNCSF Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call presents a predominantly positive operational and financial picture: constant-currency revenue and EBIT growth, strong trophon profitability and cash generation, record placements and upgrades, product innovation (trophon3/trophon2 Plus), solid annuity and service growth, a debt-free balance sheet with substantial cash and an active buyback. Management also delivered substantial regulatory and commercial progress for CORIS and set explicit FY'27 guidance that anticipates continued growth. Negative items are present but largely manageable and/or transitional: a Q3 consumables dip due to weather, margin moderation from product mix and currency, APAC softness tied to rental models, and elevated near-term OpEx to fund CORIS commercialization which will weigh on near-term profitability. Overall, highlights substantially outweigh the lowlights, with CORIS viewed as a meaningful long-term growth opportunity while trophon continues as a strong cash engine.View all NNCSF earnings summariesNNCSF Stock 12 Month Forecast
Average Price Target
$2.62
▲(28.88% Upside)
Technical Analysis
Ansell
―
Polynovo
―
Paragon Care Limited
―
Trajan Group Holdings Ltd
―
CleanSpace Holdings Ltd.
―
Ownership Overview
0.53% Insiders
3.27% Mutual Funds
0.03% Other Institutional Investors
91.60% Public Companies and
Individual Investors